276 related articles for article (PubMed ID: 7544068)
1. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome.
Benn PA; Horne D; Briganti S; Greenstein RM
Am J Obstet Gynecol; 1995 Aug; 173(2):496-501. PubMed ID: 7544068
[TBL] [Abstract][Full Text] [Related]
2. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK
Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
[TBL] [Abstract][Full Text] [Related]
3. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
[TBL] [Abstract][Full Text] [Related]
4. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
Sullivan A; Giudice T; Vavelidis F; Thiagarajah S
Am J Obstet Gynecol; 1999 Aug; 181(2):260-5. PubMed ID: 10454666
[TBL] [Abstract][Full Text] [Related]
5. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
8. The advantages of using triple-marker screening for chromosomal abnormalities.
Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S
Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448
[TBL] [Abstract][Full Text] [Related]
9. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
Nyberg DA; Luthy DA; Cheng EY; Sheley RC; Resta RG; Williams MA
Am J Obstet Gynecol; 1995 Oct; 173(4):1030-5. PubMed ID: 7485289
[TBL] [Abstract][Full Text] [Related]
10. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.
Wenstrom KD; Desai R; Owen J; DuBard MB; Boots L
Am J Obstet Gynecol; 1995 Oct; 173(4):1287-92. PubMed ID: 7485339
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
12. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Burton BK; Prins GS; Verp MS
Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
[TBL] [Abstract][Full Text] [Related]
13. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.
Crandall BF; Hanson FW; Keener S; Matsumoto M; Miller W
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1864-7; discussion 1867-9. PubMed ID: 7686337
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
Kishida T; Hoshi N; Hattori R; Negishi H; Yamada H; Okuyama K; Hanatani K; Takagi T; Sagawa T; Fujimoto S
Fetal Diagn Ther; 2000; 15(2):112-7. PubMed ID: 10720877
[TBL] [Abstract][Full Text] [Related]
16. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608
[TBL] [Abstract][Full Text] [Related]
17. The implications of a false positive second-trimester serum screen for Down syndrome.
Summers AM; Huang T; Meier C; Wyatt PR
Obstet Gynecol; 2003 Jun; 101(6):1301-6. PubMed ID: 12798540
[TBL] [Abstract][Full Text] [Related]
18. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
19. A negative second trimester triple test and absence of specific ultrasonographic markers may decrease the need for genetic amniocentesis in advanced maternal age by 60%.
Rosen DJ; Kedar I; Amiel A; Ben-Tovim T; Petel Y; Kaneti H; Tohar M; Fejgin MD
Prenat Diagn; 2002 Jan; 22(1):59-63. PubMed ID: 11810653
[TBL] [Abstract][Full Text] [Related]
20. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
